Once-weekly insulin icodec versus once-daily long-acting insulins for type 2 diabetes mellitus: Systematic review and meta-analysis

Background: Insulin icodec is a novel, long-acting, once-weekly basal insulin analog. Its comparative efficacy and safety with basal once-daily insulins in type 2 diabetes mellittus is uncertain. Objective: Evaluate potential efficacy, benefits and risks associated with icodec compared to once-daily...

Description complète

Détails bibliographiques

Auteurs principaux:	Sandro Augusto Goncalves Ribeiro, Matheus Pedrotti Chavez, Larissa Calixto Hespanhol, Caroline Cristine Almeida Balieiro, Eric Paqualotto, Rodrigo Ribeiro e Silva, Mateus Gauza, João Roberto de Sa
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2024-06-01
Collection:	Metabolism Open
Sujets:	Icodec Once-weekly insulin Once-daily insulin Glargine Degludec Type 2 diabetes mellitus
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2589936824000173
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!